FREE International Shipping on Selected Products! - Shop Now >>
  • Country Flag
  • USD
  • English
  • Shipping Country
  • Currency
  • Language
Select Category
Advisory Boards

Scientific Advisory Board

The EYSI Scientific Advisory Board (SAB) was established to make recommendations to the Group CEO and the senior management on matters of science, medicine and emerging technologies that are relevant to the growth of the Group. While innovation, research and development have long been cornerstones of growth for our subsidiaries in their individual markets, the more encompassing and consolidating perspective of the SAB will serve to optimise our research and development efforts and enhance performance for the entire Group.

The SAB provides scientific and technical guidance relating to the development of new products and capabilities for the Group, to ensure on-going relevance and innovation. It also recommends new or strategic initiatives and directions, with an emphasis on the need for scientific and evidence-based advancement of TCM in integrative health enhancement. Finally, the SAB evaluates and offers priorities for research, product development, and other related projects undertaken by the Group independently or in partnership with collaborators.

Members of the SAB are active, both locally and internationally, in research institutions, universities, clinical practice and industry. They have been appointed on the basis of their expertise in particular medical and scientific fields relevant to our goals, and to the development of the Group as a pioneering leader in the scientific advancement of TCM and the integrative healthcare industries.

The SAB consists of:

BOARD MEMBERS

Professor Chay Oh Moh
Campus Director, Education and Senior Consultant,
Respiratory Medicine Service, Department of Paediatrics,
KK Women’s and Children’s Hospital (KKH)
Professor and Paediatric Programme Leader,
Associate Designated Institutional Officer,
KKH, SingHealth Residency

Dr Seah Ching Ching, PhD
General Manager,
Research & Product Development,
Eu Yan Sang Innovation Labs, EYSI
Member of the National ISO Mirror Working Group
for Traditional Chinese Medicine, Singapore

Dr Ann Tan
Medical Director, 
Women and Fetal Centre

Morris Shriftman
Director of Strategic Initiatives, EYSI
CEO, Mozart Inc.

Professor Walter Wahli
Professor of Metabolic Disease
Lee Kong Chian School of Medicine, Nanyang Technological University
Professor Emeritus,
Center for Integrative Genomics, University of Lausanne
Pierre de Fermat Chair of Excellence Laureate,
French National Institute for Agricultural Research (INRA)
Member of the Swiss Academy of Medical Sciences
Honorary Clinical Senior Lecturer,
Faculty of Medicine, Imperial College, London
Member of the Council of the Nestlé Foundation
for the Study of Problems of Nutrition in the World

Alice Wong
Managing Director, Eu Yan Sang (Hong Kong) Limited
Member of Committee on Research & Development of Chinese Medicines, HKSAR
Member of Chinese Medicine Industry Sub-committee,
Chinese Medicines Development Committee, HKSAR
Member of Expert Group on Production Certification Scheme,
The Panel on Promoting Testing and Certification Services in Chinese

SPECIAL GUEST

Mark Blumenthal
Founder and Executive Director, American Botanical Council
Editor, HerbalGram
Senior Editor, The Complete German Commission E Monographs
Senior Editor, The ABC Clinical Guide to Herbs
Director, ABC-AHP-NCNPR Botanical Adulterants Program

SECRETARY

Shi Xuan Wong
Registered TCM Physician
Senior Executive, Eu Yan Sang Innovation Labs, EYSI

 

Medical Board

The Medical Board (MB) comprises both Western-trained medical specialists and TCM physicians to provide a balanced view of integrative medicine. Members include healthcare professionals from various medical specialities as well as representation from the clinic management.

One of the MB’s roles is overseeing standards of care in the development of TCM and Integrative Medicine clinical services for the Group and this includes the advisory on protocols for clinical documentation and clinical quality indicators. In the area of quality assurance, the MB advises on the quality and appropriateness of services provided, including clinic practices and clinic audits.

As for recruitment, the MB establishes the qualifications and experience required for prospective practitioners, and assists with interviews as well as endorsing their appointments. To ensure compliance and professionalism, the MB makes recommendations for the conduct and ethics of physicians.

Furthermore, the MB makes inquiries and investigates allegations of inappropriate conduct or practices when required.

The MB also recommends appropriate approaches to take when it comes to education and clinical research within the Group.

With these roles in mind, the MB meets at least once every quarter to elevate the clinical standards for the Group.

The MB consists of the following:

CHAIRMAN

Dr Khoo Kei Siong
Deputy Medical Director and Senior Consultant,
Medical Oncology, Parkway Cancer Centre

HEAD, REPRESENTING EYSIH

Caryn Peh
Managing Director, Clinic Services,
Eu Yan Sang Integrative Health Pte Ltd

MEDICAL SPECIALISTS

Dr Lau Tang Ching
Senior Consultant and Associate Professor,
Division of Rheumatology, University Medicine Cluster,
National University Hospital
Registered Acupuncturist

Dr Peter Loke Chi Wei
Managing Director & Family Physician, Mint Medical Centre
Partner, Resolvers Pte Ltd
Adjunct Senior Lecturer, Centre for Biomedical Ethics,
National University Hospital
Regional Medical Advisor, Syngenta Asia Pacific Pte Ltd
Principal Mediator, Singapore Mediation Centre

TCM PHYSICIANS

He Qiu Ling
Senior Physician,
Eu Yan Sang Integrative Health Pte Ltd

Zhong Xi Ming
Senior Physician,
Eu Yan Sang Integrative Health Pte Ltd

SECRETARY

Alicia Lim Sock Ling
Registered TCM Physician
Senior Executive, Clinical Affairs,
Eu Yan Sang Integrative Health Pte Ltd